跳至主要内容
临床试验/ACTRN12616000667415
ACTRN12616000667415已完成未知

Evaluation of the efficacy and mechanism of action of intense pulsed light for the treatment of meibomian gland dysfunction

The University of Auckland0 个研究点目标入组 87 人开始时间: 2016年5月23日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
入组人数
87

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Treatment
盲法
Blinded (masking used)

入排标准

年龄范围
18 Years 至 o limit(—)
性别
All

入选标准

  • Participants with symptomatic dry eye caused by meibomian gland dysfunction.

排除标准

  • Contraindications to light therapy e.g. clinical skin treatments within last two months, implants beneath the lower eyelid area, tattoos, semi-permanent make-up, or pigmented lesions in the treatment area will also be excluded from the study. Contact lens wearers must refrain from wearing contacts within one week of commencing the study, and during the study. Individuals taking prescribed photosensitising medications such as doxycycline within 3 months of study commencement.

研究者

相似试验